Top 8 things medical device companies need to know after the Prescribed List reforms
For medical device companies seeking reimbursement in the Australian private hospital system, inclusion on the Prescribed List (PL) remains critical. What has […]
Author: admin
MFN 2.0: How the US GENEROUS model could quietly reshape global pricing and put Australia on the back foot
On 6 November 2025, the US Centers for Medicare & Medicaid Services (CMS) announced the GENEROUS (GENErating cost Reductions fOr US Medicaid) […]
What pharma companies need to know about the new PBS Notice of Intent requirements
The Department of Health, Disability and Ageing has announced changes to their PBS Notice of Intent (NOI) process that will impact your […]
Market Access Forum for Pharma Industry Professionals
Attend our Market Access Forum tailored for professionals in the pharmaceutical industry! This event provides a unique platform to network with fellow […]
We’ve joined the National AI Centre’s AI Directory
Exciting news! Pulse Economics is proud to be listed on the National AI Centre’s AI Directory, a platform showcasing Australia’s AI capabilities […]
Future proofing HTA: critical conversations for Australian healthcare
Key challenges and opportunities shaping health technology assessment Next Tuesday’s ISPOR workshop brings together Australia’s leading HTA stakeholders: PBAC members, HTA Review […]
The digital health market access challenge in Australia
What we’re seeing We’ve been working with some remarkable Australian digital health companies lately. These are teams with genuinely impressive clinical evidence […]
Kosi Challenge – March 2025
This weekend, our Pulse Economics team took on the Kosi Challenge, climbing Mt Kosciuszko to shine a light on rare cancers. We’re […]
Keeping pace with PBAC and MSAC key dates
Staying ahead in the pharma and medtech sectors requires a deep understanding of regulatory and advisory timelines, such as those set by […]
Positioning Australia’s life sciences industry for global success
Australia is a leader in niche life science segments with strong global markets, including plasma therapies, hearing implants, and sleep apnoea devices. […]